3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
1
Interventions
Saline Solution
6
Dexmedetomidine
5
Sodium Chloride
4
Temozolomide
3
Sevoflurane
3
Propofol
3
Methotrexate
3
Levetiracetam
3
trametinib
2
perampanel
2
dabrafenib
2
Sugammadex
2
Neuroimaging
2
Methylphenidate
2
Magnetic Resonance Spectroscopy
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Gentamicins
2
Fluorescein
2
Anesthesia, Inhalation
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
pembrolizumab
1
pegvisomant
1
olutasidenib
1
naxitamab
1
lorlatinib
1
gadoterate meglumine
1
gadobenic acid
1
durvalumab
1
dexketoprofen trometamol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Fluoresceins
×
CNS
×
Clear all
NCT02028325
2016-11-08
Fluorescein
Indiana University
Phase 4
Terminated
136 enrolled
4 charts